BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4754717)

  • 1. A peptide released from plasma fibrin stabilzing factor in the conversion to the active enzyme by thrombin.
    Mikuni Y; Iwanaga S; Konishi K
    Biochem Biophys Res Commun; 1973 Oct; 54(4):1393-403. PubMed ID: 4754717
    [No Abstract]   [Full Text] [Related]  

  • 2. Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin.
    Takagi T; Doolittle RF
    Biochemistry; 1974 Feb; 13(4):750-6. PubMed ID: 4811064
    [No Abstract]   [Full Text] [Related]  

  • 3. On the activation of bovine plasma factor XIII. Amino acid sequence of the peptide released by thrombin and the terminal residues of the subunit polypeptides.
    Nakamura S; Iwanaga S; Suzuki T
    J Biochem; 1975 Dec; 78(6):1247-66. PubMed ID: 1225922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of platelet fibrin-stabilizing factor by thrombin.
    Hung GW; Sonnichsen WJ; James HL; Ganguly P
    Biochim Biophys Acta; 1974 Dec; 371(2):511-8. PubMed ID: 4215455
    [No Abstract]   [Full Text] [Related]  

  • 6. Amino acid sequence of the peptide released from bovine factor XIII following activation by thrombin.
    Nakamura S; Iwanaga S; Suzuki T; Mikuni Y; Konishi K
    Biochem Biophys Res Commun; 1974 May; 58(1):250-6. PubMed ID: 4831071
    [No Abstract]   [Full Text] [Related]  

  • 7. Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII.
    Yee VC; Pedersen LC; Bishop PD; Stenkamp RE; Teller DC
    Thromb Res; 1995 Jun; 78(5):389-97. PubMed ID: 7660355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microheterogeneity of cross-linked gamma dimers isolated from bovine stabilized fibrin.
    Okude M; Iwanaga S
    Biochem Biophys Res Commun; 1973 Sep; 54(1):53-61. PubMed ID: 4795370
    [No Abstract]   [Full Text] [Related]  

  • 9. Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Biol Chem; 1973 Feb; 248(4):1395-407. PubMed ID: 4405643
    [No Abstract]   [Full Text] [Related]  

  • 10. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 11. Titration and subunit localization of active center cysteine in fibrinoligase (thrombin-activated fibrin stabilizing fector).
    Curtis CG; Stenberg P; Chou CH; Gray A; Brown KL; Lorand L
    Biochem Biophys Res Commun; 1973 May; 52(1):51-6. PubMed ID: 4736472
    [No Abstract]   [Full Text] [Related]  

  • 12. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41).
    Isetti G; Maurer MC
    J Pept Res; 2004 Mar; 63(3):241-52. PubMed ID: 15049836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The subunit structures of human plasma and platelet factor XIII (fibrin-stabilizing factor).
    Schwartz ML; Pizzo SV; Hill RL; McKee PA
    J Biol Chem; 1971 Sep; 246(18):5851-4. PubMed ID: 5096097
    [No Abstract]   [Full Text] [Related]  

  • 14. [Identification of a (D-D)...E complex in degradation products of bovine fibrin stabilized by factor XIII].
    Hudry-Clergeon G; Paturel L; Suscillon M
    Pathol Biol (Paris); 1974 Nov; 22 suppl():47-52. PubMed ID: 4620095
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures.
    Chung SI; Lewis MS; Folk JE
    J Biol Chem; 1974 Feb; 249(3):940-50. PubMed ID: 4149557
    [No Abstract]   [Full Text] [Related]  

  • 16. V34I and V34A substitutions within the factor XIII activation peptide segment (28-41) affect interactions with the thrombin active site.
    Trumbo TA; Maurer MC
    Thromb Haemost; 2003 Apr; 89(4):647-53. PubMed ID: 12669118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and properties of a coagulant thrombin-like enzyme from the venom of Bothrops leucurus.
    Magalhães A; Magalhães HP; Richardson M; Gontijo S; Ferreira RN; Almeida AP; Sanchez EF
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):565-75. PubMed ID: 16481207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of fibrinopeptides formed during intravascular coagulation in dogs.
    Gröndahl NJ; Miller SP; Teger-Nilsson AC
    Acta Physiol Scand; 1969 Jul; 76(3):369-75. PubMed ID: 5823868
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrin cross-linking in congenital factor XIII deficiency.
    Rodeghiero F; Barbui T
    J Clin Pathol; 1980 May; 33(5):434-7. PubMed ID: 7400341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large scale preparation of S-carboxymethylated chains of human fibrin and fibrinogen and the occurrence of -chain variants.
    Henschen A; Edman P
    Biochim Biophys Acta; 1972 Apr; 263(2):351-67. PubMed ID: 5031163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.